United States-Israel Health Technologies Cooperation Act

HR 4076 establishes a joint U.S.-Israel program to fund health technology development, authorizing $4 million annually (2024-2026) through the U.S. Health and Human Services Department. It requires Israel to match U.S. funding and focuses on collaborative projects in artificial intelligence, vaccines, telemedicine, diagnostic tests, and data-driven personalized medicine for emerging infectious diseases. The program can either build on an existing U.S.-Israel agreement or create a new one under a 2008 science cooperation framework. This bill directly affects U.S. federal health agencies and the Israeli government, with funds restricted to joint projects meeting specific technological and health priorities.